Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies-Reference-Cited by-同舟云学术

Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies

Published:2018-10 Issue: Volume:106 Page:956-965
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Hoxha Malvina,Lewis-Mikhael Anne-Mary,Bueno-Cavanillas Aurora^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference46 articles.

1. Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends;Capra;Med. Res. Rev.,2007

2. Leukotrienes in cardiovascular diseases;Folco;Am. J. Respir. Crit. Care Med.,2000

3. International union of basic and clinical pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions;Bäck;Pharmacol. Rev.,2011

4. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries;Allen;Circulation,1998

5. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis;Spanbroek;Proc. Natl. Acad. Sci.,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus;Antimicrobial Agents and Chemotherapy;2024-07-09

2. Cross-talk between bioactive lipid mediators and the unfolded protein response in ischemic stroke;Prostaglandins & Other Lipid Mediators;2023-10

3. Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs;Pharmaceuticals;2023-09-01

4. Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications;Kardiologia Polska;2023-03-27

5. Montelukast and Acute Coronary Syndrome: The Endowed Drug;Pharmaceuticals;2022-09-14